Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Janux Has A License To Thrill With 007’s Prostate Cancer Results
Dec 04 2024
•
By
Andrew McConaghie
CellCentric says it has a first-in-class prostate cancer therapy • Source: Shutterstock
More from Clinical Trials
More from Scrip